Psoriasis Severity, Comorbidities, and Treatment Response Differ among Geographic Regions in the United States
Clinton Enos, Katie A. O’Connell, Ryan W. Harrison, Robert R. McLean, Blessing Dube, Abby S. Van Voorhees
Abstract
= 0.010) regions compared with those observed among patients in the Northeast. The East South Central and West South Central regions may have the greatest frequencies of very severe disease burden and, along with the Pacific region, may be less likely to achieve targeted response within 6 months of initiating biologic therapy.
Topics & Concepts
Confidence intervalBody mass indexMedicineOdds ratioDemographyObesityPsoriasisLogistic regressionDemographicsInternal medicinePsoriasis Area and Severity IndexOddsImmunologySociologyPsoriasis: Treatment and PathogenesisDermatology and Skin DiseasesHealth Systems, Economic Evaluations, Quality of Life